Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1

Carly Behm -  

Stryker, Johnson & Johnson and Zimmer Biomet all saw first-quarter revenue increases. The devicemakers also saw overall growth in their spine and orthopedic segments year over year.

Here is how their first-quarter performances compare:

Stryker

Total sales: $4.3 billion (+8.1 percent) 

Spine: $279 million (+0.1 percent)

Orthopedic: $1.9 billion (+8.1 percent)

Hips: $327 million (+5.9 percent)

Knees: $464 million (+12.5 percent)

 

Johnson & Johnson

Total sales: $23.4 billion (+5 percent)

Spine, sports and other: $712 million (+0.6 percent)

Orthopedic: $2.2 billion (+3.5 percent)

Hips: $389 million (+9.3 percent)

Knees: $339 million (+6.7 percent)

 

Zimmer Biomet

Total sales: $1.7 billion (+3.9 percent)

Hips: $451 million (+0.9 percent)

Knees: $662.8 million (+7.9 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $416.8 million (-0.2 percent)

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast